Report Scope & Overview:
Biohacking Market size was valued at USD 22.17 billion in 2022 and is expected to reach at USD 90.36 billion by 2030, and grow at a CAGR of 19.2% over the forecast period of 2023-2030.
The major objective behind the biohacking system is to improve the heath quality and bringing up the new intentional health related strategies, biohacking system is denoted as DO it yourself, there are different Product Type of biohacking in healthcare some of the major once includes your health, diet, healthy lifestyle and so forth.
Biohacking is basically a function in which a person can work towards their health and fitness goals by themselves, with the latest innovations of the technology which supports and makes it easy for the person to perform bio-hacking activities is what drives the market in a positive manner, the rising concern of health-related issues all around the globed is the major factor the demand for the biohacking is high. There are different Product Type of therapies which are used in biohacking which helps an individual to deal with the health-related concerns, the latest technology upgradation by the key players in order to the match the rising demand and high adaptability rate is the opportunistic factors which contribute to the growth of the biohacking market.
Impact of Covid 19
The rising R&D and the rising demand for the testing kits and vaccines the use of biohacking was probably done but the approval was a major concern, the major concerns which biohacking market faced during the pandemic was the disruptions of global supply chain management which made to difficulty for the key players and organizations to deal with the availability of raw materials. And also, the rising awareness of the biohacking system where people were more focus on to their heat as health was the major propriety of the people during the pandemic, the rise in the awareness regarding the benefits of consumption of healthy food leads to the positive impact of biotechnology market.
Market Dynamics
Drivers
The rising health concerns all around the globe.
The rise in the health related concerns is considered as the driving factor for the biohacking market because people in the developed and emerging countries are more focused on prioritizing their health, The rising cardiovascular disease all around the globe and the rising diabetes, patients contribute to the growth of the biohacking market, the lifestyle of the people in the developed countries make it more difficult for the people to focus on their health the other reason include work related stress in the developed and the emerging cities of the developed regions which increase the demand for the biohacking system.
Restrain
Lack of awareness in the undeveloped region.
The biohacking system in the underdeveloped region is less known to the people because of the lack of awareness and the facilities and access to the latest technology to the people of those region.
Opportunity
The increase in the R&D and the rising number of innovation by the key players.
The latest technological upgradation and the innovation of the new products done by the key players in order to match the rising demand are the opportunistic factor which will contribute to the growth of the biohacking market during the forecasted period.
Market segmentation
By Product Type:
Wearables
Implants
Gene Modification Kits
Smart drugs
Supplements
Mobile Apps
Others
By Applications:
Monitoring
Treatment
Research
Others
By End User:
Pharmaceutical companies & Biotechnology Companies
Hospitals & Clinics
Forensic Laboratories
Research & Academic Institutes
Others
.png)
Regional Analysis
North America is said to be the region which will dominate the market because of the rise in the demand for the biohacking practises and the rising concern related to the health benefits and also the fact that the rising number of patients suffering from cardiovascular disease and other health related benefits is said to be the factors which contribute to the growth of biohacking market in the North America region.
Asia pacific is said to be the region with the highest CAGR growth rate because of the rising initiatives taken by the government and the rise in the number of startups which contribute to the growth of the biohacking practices and also the rising awareness of the biohacking system in the developed and the emerging cities of APAC region are the regions which plays a crucial role in terms of growth.
By Region
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Key Players
The major key players are Apple, Inc, The Odin, Thync Global, Fitbit Inc, MoodMetric, HVMN Inc, Muse, ThrivePort, LLC, TrackmyStack, OSteoStrong.
Thync Global-Company Financial Analysis
Latest development
Apple Inc; With the help of apple watch the user can clearly keep a track of their heart because of the additional features of heartrate, ECG, irregular rhythm information’s which gives the upper edge for the company compared to the other competitors.
The initiative taken by the ODIN company to build design and custom engineering products which will be easy to use in the labs and at home by the customers.
Thync Global;
The launch of KETONE-IQ by HVMN, Inc
Ketones-Iq is considered as a nutritional and unique product which can be used for metabolic health and performance.
| Report Attributes | Details |
| Market Size in 2022 | US$ 22.17 Bn |
| Market Size by 2030 | US$ 90.36 Bn |
| CAGR | CAGR of 19.2% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product Type (Wearables Implants, Gene Modification Kits, Smart drugs, Supplements, Mobile Apps, Others) • By Applications (Monitoring, Treatment, Research, Others) • By End User (Pharmaceutical companies & Biotechnology Companies, Hospitals & Clinics, Forensic Laboratories, Research & Academic Institutes, Others) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Apple, Inc, The Odin, Thync Global, Fitbit Inc, MoodMetric, HVMN Inc, Muse, ThrivePort, LLC, TrackmyStack, OSteoStrong. |
| Key Drivers | • The rising health concerns all around the globe. |
| Market Opportunities | • The increase in the R&D and the rising number of innovation by the key players. |
Ans: The Biohacking Market size was valued at USD 22.17 billion in 2022 and is expected to reach at USD 90.36 billion by 2030, and grow at a CAGR of 19.2% over the forecast period of 2023-2030.
Ans: Lack of awareness in the undeveloped region.
Ans: The major key players are Apple, Inc, The Odin, Thync Global, Fitbit Inc, MoodMetric, HVMN Inc, Muse, ThrivePort, LLC, TrackmyStack, OSteoStrong.
Ans: The major concerns which biohacking market faced during the pandemic was the disruptions of global supply chain management.
Ans: North America is dominating the market and will continue to dominate the market during the forecasted period.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID 19 Impact Analysis
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Biohacking Market Segmentation, By Product Type
8.1 Wearables
8.2 Implants
8.3 Gene Modification Kits
8.4 Smart drugs
8.5 Supplements
8.6 Mobile Apps
8.7 Others
9. Biohacking Market Segmentation, By Applications
9.1 Monitoring
9.2 Treatment
9.3 Research
9.4 Others
10. Biohacking Market Segmentation, By End User
10.1 Pharmaceutical companies & Biotechnology Companies
10.2 Hospitals & Clinics
10.3 Forensic Laboratories
10.4 Research & Academic Institutes
10.5 Others
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America Biohacking Market by country
11.2.2North America Biohacking Market by Product Type
11.2.3 North America Biohacking Market by Applications
11.2.4 North America Biohacking Market by End User
11.2.5 USA
11.2.5.1 USA Biohacking Market by Product Type
11.2.5.3 USA Biohacking Market by Applications
11.2.5.4 USA Biohacking Market by End User
11.2.6 Canada
11.2.6.1 Canada Biohacking Market by Product Type
11.2.6.3 Canada Biohacking Market by Applications
11.2.6.4 Canada Biohacking Market by End User
11.2.7 Mexico
11.2.7.1 Mexico Biohacking Market by Product Type
11.2.7.3 Mexico Biohacking Market by Applications
11.2.7.4 Mexico Biohacking Market by End User
11.3 Europe
11.3.1 Europe Biohacking Market by country
1.3.3.2 Europe Biohacking Market by Product Type
11.3.3 Europe Biohacking Market by Applications
11.3.4 Europe Biohacking Market by End User
11.3.5 Germany
11.3.5.1 Germany Biohacking Market by Product Type
11.3.5.2 Germany Biohacking Market by Applications
11.3.5.3 Germany Biohacking Market by End User
11.3.6 UK
11.3.6.1 UK Biohacking Market by Product Type
11.3.6.2 UK Biohacking Market by Applications
11.3.6.3 UK Biohacking Market by End User
11.3.7 France
11.3.7.1 France Biohacking Market by Product Type
11.3.7.2 France Biohacking Market by Applications
11.3.7.3 France Biohacking Market by End User
11.3.8 Italy
11.3.8.1 Italy Biohacking Market by Product Type
11.3.8.2 Italy Biohacking Market by Applications
11.3.8.3 Italy Biohacking Market by End User
11.3.9 Spain
11.3.9.1 Spain Biohacking Market by Product Type
11.3.9.2 Spain Biohacking Market by Applications
11.3.9.3 Spain Biohacking Market by End User
11.3.10 The Netherlands
11.3.10.1 Netherlands Biohacking Market by Product Type
11.3.10.2 Netherlands Biohacking Market by Applications
11.3.10.3 Netherlands Biohacking Market by End User
11.3.11 Rest of Europe
11.3.11.1 Rest of Europe Biohacking Market by Product Type
11.3.11.2 Rest of Europe Biohacking Market by Applications
11.3.11.3 Rest of Europe Biohacking Market by End User
11.4 Asia-Pacific
11.4.1 Asia Pacific Biohacking Market by country
11.4.2 Asia Pacific Biohacking Market by Product Type
11.4.3 Asia Pacific Biohacking Market by Applications
11.4.4 Asia Pacific Biohacking Market by End User
11.4.5 Japan
11.4.5.1 Japan Biohacking Market by Product Type
11.4.5.2 Japan Biohacking Market by Applications
11.4.5.3 Japan Biohacking Market by End User
11.4.6 South Korea
11.4.6.1 South Korea Biohacking Market by Product Type
11.4.6.2 South Korea Biohacking Market by Applications
11.4.6.3 South Korea Biohacking Market by End User
11.4.7 China
11.4.7.1 China Biohacking Market by Product Type
11.4.7.2 China Biohacking Market by Applications
11.4.7.3 China Biohacking Market by End User
11.4.8 India
11.4.8.1 India Biohacking Market by Product Type
11.4.8.2 India Biohacking Market by Applications
11.4.8.3 India Biohacking Market by End User
11.4.9 Australia
11.4.9.1 Australia Biohacking Market by Product Type
11.4.9.2 Australia Biohacking Market by Applications
11.4.9.3 Australia Biohacking Market by End User
11.4.10 Rest of Asia-Pacific
11.4.10.1 APAC Biohacking Market by Product Type
11.4.10.2 APAC Biohacking Market by Applications
11.4.10.3 APAC Biohacking Market by End User
11.5 The Middle East & Africa
11.5.1 The Middle East & Africa Biohacking Market by country
11.5.2 The Middle East & Africa Biohacking Market by Product Type
11.5.3 The Middle East & Africa Biohacking Market by Applications
11.5.4 The Middle East & Africa Biohacking Market by End User
11.5.6 Israel
11.5.6.1 Israel Biohacking Market by Product Type
11.5.6.2 Israel Biohacking Market by Applications
11.5.6.3 Israel Biohacking Market by End User
11.5.6 UAE
11.5.6.1 UAE Biohacking Market by Product Type
11.5.6.2 UAE Biohacking Market by Applications
11.5.6.3 UAE Biohacking Market by End User
11.5.7 South Africa
11.5.7.1 South Africa Biohacking Market by Product Type
11.5.7.2 South Africa Biohacking Market by Applications
11.5.7.3 South Africa Biohacking Market by End User
11.5.8 Rest of Middle East & Africa
11.5.8.1 Rest of Middle East & Asia Biohacking Market by Product Type
11.5.8.2 Rest of Middle East & Asia Biohacking Market Phase
11.5.8.3 Rest of Middle East & Asia Biohacking Market by End User
11.6 Latin America
11.6.1 Latin America Biohacking Market by country
11.6.2 Latin America Biohacking Market by Product Type
11.6.3 Latin America Biohacking Market by Applications
11.6.4 Latin America Biohacking Market by End User
11.6.5 Brazil
11.6.5.1 Brazil Biohacking Market by Product Type
11.6.5.2 Brazil Biohacking Market by Applications
11.6.2.3 Brazil Biohacking Market by End User
11.6.6 Argentina
11.6.6.1 Argentina Biohacking Market by Product Type
11.6.6.3 Argentina Biohacking Market by Applications
11.6.6.4 Argentina Biohacking Market by End User
11.6.7 Rest of Latin America
11.6.7.1 Rest of Latin America Biohacking Market by Product Type
11.6.7.3 Rest of Latin America Biohacking Market by Applications
11.6.7.4 Rest of Latin America Biohacking Market by End User
12 Company profile
12.1 Apple, Inc
12.1.1 Market Overview
12.1.2 Financials
12.1.3 Treatment/Services/Offerings
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 The Odin
12.2.1 Market Overview
12.2.2 Financials
12.2.3 Treatment/Services/Offerings
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 Thync Global
12.3.1 Market Overview
12.3.2 Financials
12.3.3 Treatment/Services/Offerings
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Fitbit, Inc
12.4.1 Market Overview
12.4.2 Financials
12.4.3 Treatment/Services/Offerings
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 MoodMetric
12.5.1 Market Overview
12.5.2 Financials
12.5.3 Treatment/Services/Offerings
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 HVMN, Inc
12.6.1 Market Overview
12.6.2 Financials
12.6.3 Treatment/Services/Offerings
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 Muse
12.7.1 Market Overview
12.7.2 Financials
12.7.3 Treatment/Services/Offerings
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 ThrivePort, LLC
12.8.1 Market Overview
12.8.2 Financials
12.8.3 Treatment/Services/Offerings
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 TrackmyStack
12.9.1 Market Overview
12.9.2 Financials
12.9.3 Treatment/Services/Offerings
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 OSteoStrong
12.10.1 Market Overview
12.10.2 Financials
12.10.3 Treatment/Services/Offerings
12.10.4 SWOT Analysis
12.10.5 The SNS View
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share analysis
13.3 Recent Developments
14. Used Cases & Best practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Dental Biomaterials market size is projected to grow from $5.6 billion in 2022 to $8.70 billion by 2030, at a CAGR of 5.91% during the forecast period.
The Healthcare Interoperability Solutions Market Size was valued at USD 2.98 billion in 2022, and is expected to reach USD 8.38 billion by 2030 and grow at a CAGR of 13.8% over the forecast period 2023-2030.
The Low-Pressure Liquid Chromatography Market Size was valued at USD 6.77 billion in 2022, and is expected to reach USD 12.07 billion by 2030, and grow at a CAGR of 7.5% over the forecast period 2023-2030.
The Blockchain Technology in Healthcare Market Size was valued at USD 3.3 billion in 2023 and is expected to reach USD 214.44 billion by 2031, and grow at a CAGR of 68.5% over the forecast period 2024-2031.
The Surgical Retractors Market Size was valued at USD 2.03 billion in 2023, and is expected to reach USD 3.54 billion by 2031, and grow at a CAGR of 6.8% over the forecast period 2024-2031.
The Medical Image Analysis Software Market Size was valued at USD 3 billion in 2022 and is expected to reach USD 5.27 billion by 2030 and grow at a CAGR of 7.3% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
